Indian Journal of PsychiatryIndian Journal of Psychiatry
Home | About us | Current Issue | Archives | Ahead of Print | Submission | Instructions | Subscribe | Advertise | Contact | Login 
    Users online: 1228 Small font sizeDefault font sizeIncrease font size Print this article Email this article Bookmark this page
Read this article

 


    Article Cited by others

ORIGINAL ARTICLE

Drug-emergent metabolic syndrome in patients with schizophrenia receiving atypical (second-generation) antipsychotics

Gautam Shiv, Meena Parth Singh

Year : 2011| Volume: 53| Issue : 2 | Page no: 128-133

   This article has been cited by
 
1 Patterns and predictors of oral antipsychotic prescribing in adult patients with schizophrenia
Nina Vadiei, Jasim El-Ali, Joss Delaune, Cecilia Wild, Yi-Shao Liu
Exploratory Research in Clinical and Social Pharmacy. 2022; : 100148
[Pubmed]  [Google Scholar] [DOI]
2 Study of the acute and repeated dose 28-day oral toxicity in mice treated with PT-31, a molecule with potential antipsychotic profile
Thalia Emmanoella Sebulsqui Saraiva, Gabriela Zimmermann Prado Rodrigues, Juliana Machado Kayser, Eliane Dallegrave, Nathália Pulz Maus, Andriele Veiverberg, Gabriel da Costa Berna, Andriéli Carolina Schuster, Maria Gabriela de Freitas, Marina Galdino da Rocha Pitta, Ivan da Rocha Pitta, Günther Gehlen, Andresa Heemann Betti
Toxicology Mechanisms and Methods. 2022; : 1
[Pubmed]  [Google Scholar] [DOI]
3 The development of the Metabolic-associated Fatty Liver Disease during pharmacotherapy of mental disorders - a review
Jakub Krzysztof Rogalski, Aleksandra Subdys, Oliwia Ewa Gawlik-Kotelnicka
Current Problems of Psychiatry. 2022; 0(0)
[Pubmed]  [Google Scholar] [DOI]
4 METABOLIC SYNDROME IN PATIENTS WITH PSYCHOSIS USING SECOND-GENERATION ANTIPSYCHOTICS
Sarath Chandra Ivaturi, Sri Ramya, Syed Zainab
PARIPEX INDIAN JOURNAL OF RESEARCH. 2022; : 33
[Pubmed]  [Google Scholar] [DOI]
5 Impacts of 2012 update to the AGS beers criteria on potentially inappropriate antipsychotic medication use among older adults
Dooyoung Lim, Darren Liu, Betty Burston
Aging and Health Research. 2021; 1(3): 100025
[Pubmed]  [Google Scholar] [DOI]
6 The prevalence of mental health medication use in a cohort of New Zealand patients with diabetes
Lynne Chepulis, Brittany Morison, Chunhuan Lao, Rawiri Keenan, Ryan Paul, Ross Lawrenson
Primary Care Diabetes. 2020; 14(6): 703
[Pubmed]  [Google Scholar] [DOI]
7 A Study of Metabolic Syndrome in Patients on Risperidone
Ajay Thangraj, Nimesh G. Desai, Vijender Singh
Current Psychopharmacology. 2020; 9(3): 218
[Pubmed]  [Google Scholar] [DOI]
8 Effects of olanzapine treatment on lipid profiles in patients with schizophrenia: a systematic review and meta-analysis
Rong Li, Yiqi Zhang, Wenqiang Zhu, Chen Ding, Wenjie Dai, Xin Su, Wen Dai, Jingmei Xiao, Zhenhua Xing, Xiansheng Huang
Scientific Reports. 2020; 10(1)
[Pubmed]  [Google Scholar] [DOI]
9 Early Detection of Metabolic Abnormalities in Patients with Newly Diagnosed Schizophrenia on Atypical Antipsychotics
Rochlani D, Lahariya S, Bansal S.K
Journal of Evolution of Medical and Dental Sciences. 2019; 8(43): 3229
[Pubmed]  [Google Scholar] [DOI]
10 METABOLIC SIDE EFFECTS OF HALOPERIDOL AND RISPERIDONE- A SIX MONTHS FOLLOWUP STUDY
Kalaimathi B, Mohamed Ilyas Rahamathulla M, Mohana Lakshmi M, Alexander Gnana Durai W.J, Saravana Jothi R, Priyadharshini R, Jeevitha K
Journal of Evidence Based Medicine and Healthcare. 2017; 3(25): 1463
[Pubmed]  [Google Scholar] [DOI]
11 Effects of clozapine on adipokine secretions/productions and lipid droplets in 3T3-L1 adipocytes
Tomomi Tsubai, Akira Yoshimi, Yoji Hamada, Makoto Nakao, Hiroshi Arima, Yutaka Oiso, Yukihiro Noda
Journal of Pharmacological Sciences. 2017; 133(2): 79
[Pubmed]  [Google Scholar] [DOI]
12 Obesity, adipokines and neuroinflammation
Argel Aguilar-Valles,Wataru Inoue,Christoph Rummel,Giamal N. Luheshi
Neuropharmacology. 2015;
[Pubmed]  [Google Scholar] [DOI]
13 Metabolic syndrome in antipsychotic naďve patients with schizophrenia: pooled analysis of data from three Indian studies
Sandeep Grover,Naresh Nebhinani,Ramachandran Padmavati,Rakesh K Chadda,Srinivasan Tirupati,Abhishek Pallava
Early Intervention in Psychiatry. 2014; : n/a
[Pubmed]  [Google Scholar] [DOI]
14 Obesity and psychiatric disorders: Commonalities in dysregulated biological pathways and their implications for treatment
Adrian L. Lopresti,Peter D. Drummond
Progress in Neuro-Psychopharmacology and Biological Psychiatry. 2013; 45: 92
[Pubmed]  [Google Scholar] [DOI]
15 Genetic Variants of Microsomal Triglyceride Transfer Protein (MTTP) Are Associated With Metabolic Syndrome in Schizophrenic Patients Treated With Atypical Antipsychotics
Ying-Jay Liou,Shih-Jen Tsai,Ying-Chieh Wang,Ya Mei Bai,Chen-Jee Hong
Journal of Clinical Psychopharmacology. 2013; 33(3): 313
[Pubmed]  [Google Scholar] [DOI]
16 Increased Framingham 10-year CVD risk in Chinese patients with schizophrenia
Yi Hang Tay,Milawaty Nurjono,Jimmy Lee
Schizophrenia Research. 2013; 147(1): 187
[Pubmed]  [Google Scholar] [DOI]
17 Histopathological change of the endocrine pancreas in male albino rat treated with the atypical antipsychotic clozapine
Abdelrahim, E.A.
Romanian Journal of Morphology and Embryology. 2013; 54(2): 385-394
[Pubmed]  [Google Scholar]
18 Detection of Metabolic Syndrome in Schizophrenia and Implications for Antipsychotic Therapy
Kyle J. Burghardt,Vicki L. Ellingrod
Molecular Diagnosis & Therapy. 2013; 17(1): 21
[Pubmed]  [Google Scholar] [DOI]
19 Obesity and psychiatric disorders: Commonalities in dysregulated biological pathways and their implications for treatment
Lopresti, A.L. and Drummond, P.D.
Progress in Neuro-Psychopharmacology and Biological Psychiatry. 2013; 45: 92-99
[Pubmed]  [Google Scholar]
20 Genetic variants of microsomal triglyceride transfer protein (mttp) are associated with metabolic syndrome in schizophrenic patients treated with atypical antipsychotics
Liou, Y.-J. and Tsai, S.-J. and Wang, Y.-C. and Bai, Y.M. and Hong, C.-J.
Journal of Clinical Psychopharmacology. 2013; 33(3): 313-318
[Pubmed]  [Google Scholar]
21 Increased Framingham 10-year CVD risk in Chinese patients with schizophrenia
Tay, Y.H. and Nurjono, M. and Lee, J.
Schizophrenia Research. 2013; 147(1): 187-192
[Pubmed]  [Google Scholar]
22 Detection of metabolic syndrome in schizophrenia and implications for antipsychotic therapy: Is there a role for folate?
Burghardt, K.J. and Ellingrod, V.L.
Molecular Diagnosis and Therapy. 2013; 17(1): 21-30
[Pubmed]  [Google Scholar]
23 Relevant issues in pharmacotherapy of psycho-cutaneous disorders
Ghosh, S. and Behere, R.V. and Sharma, P.S.V.N. and Savitha, S.
Indian Journal of Dermatology. 2013; 58(1): 61-64
[Pubmed]  [Google Scholar]
24 Toxicology and overdose of atypical antipsychotics
Minns, A.B. and Clark, R.F.
Journal of Emergency Medicine. 2012; 43(5): 906-913
[Pubmed]  [Google Scholar]
25 Metabolic syndrome in relation to psychotropic polypharmacy
Steylen, P.M.J. and van der Heijden, F.M.M.A. and Kok, H.D.H. and Sijben, N.A.S. and Verhoeven, W.M.A.
Clinical Neuropsychiatry. 2012; 9(2): 75-83
[Pubmed]  [Google Scholar]
26 Toxicology and Overdose of Atypical Antipsychotics
Alicia B. Minns,Richard F. Clark
The Journal of Emergency Medicine. 2012; 43(5): 906
[Pubmed]  [Google Scholar] [DOI]
27 Schizophrenia and folate pharmacogenetics: Review of the literature regarding folic acid and its pharmacogenetically regulated metabolism in relation to schizophrenia treatments
Andrew Wechter,Kristen N. Gardner,Tyler B. Grove,Vicki L. Ellingrod
Mental Health Clinician. 2012; 1(9): 225
[Pubmed]  [Google Scholar] [DOI]